TransCure Bioservices

Archamps, (3 April 2023) – TransCure bioServices, a unique fee-for-service Humanized Mouse Preclinical CRO, has announced two new additions to their workforce to further improve their already strong animal welfare policy. Dr Solenn Percelay, PhD will join the team as an Animal Welfare Scientist, and Dr NoÈmie Spinelli, DVM, as an on-site veterinarian, strengthening the…

Archamps, 6 March 2023 – TransCure bioServices has developed cell line-derived xenograft (CDX) mouse models that will change how researchers tackle the preclinical studies of cancer therapies to treat acute myeloid leukemia (AML). These models enable deeper insights into the efficacy and toxicity of AML therapies, leading to the development of better treatments and bringing…